|
|
 |
 |
|
May 16, 2002 |
Corporate name: Kobayashi Pharmaceutical Co., Ltd.
Chief Executive: Kazumasa KOBAYASHI, President & CEO
(Code No. 4967 The First Section of TSE/OSE) |
|
 |
Notice of acquisition
of treasury stocks
(Acquisition of treasury stocks pursuant to Article 210 of the
Commercial Code) |
It is hereby notified that at the Directors' Meeting held on
16th May 2002, the Kobayashi has resolved to acquire treasury
stocks pursuant to Article 210 of the Commercial Code.
|
|
1.
|
Reason for acquisition
of treasury stocks
For more flexible management of the Company to enable
it to adapt to change.
|
|
2.
|
Details of the acquisition
| (1)Type
of shares to be acquired: |
common stock in
the Company |
| (2)Total number
of shares to be acquired: |
600,000 stocks(at the
maximum)
(2.11% of total stocks outstanding) |
| (3)Total amount
of shares to be acquired: |
¥3 billion(at the maximum) |
|
| (cf.) |
Above is subject to approval
and resolution of "acquisition of treasury
stocks" at the general meeting of shareholders
of the Company to be held on 27th June 2002. |
|
|
|
|
|
|
|
